Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis // Can. <...> Berberat P. O., Friess H., Uhl W., Buchler M. W. The role of octreotide in prevention of complication following pancreatic resection // Digestion. 1999. <...> Gouillat C., Gigot J.-F. Pancreatic surgical complications — the case for profilaxis // Gut. 2001. <...> Management of enterocutaneos fistulas: 30-year clinical experience // Chin. Med. <...> Li-Ling J., Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized, controlled trials // Br. <...> Does Octreotide has any beneficial effect in patients with high risk to develop pancreatic fistula after pancreaticoduodenectomy: a prospective randomized trial / The society for surgery of the alimentary tract. <...> The Department of Surgical Education, Orlando Regional Medical Center. <...> Tulassay Z., Flautner L., Vadasz A., Fehervari I. Shot report: octreotide in the treatment of external pancreatic fistulas // Alimentary Pharmacology & Therapeutics. 1993. <...> Vanounou T., Pratt W. B., Callery M. P., Vollmer C. M. Jr. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high — risk glands // J. Am. <...> Octreotide plus total parenteral nutrition in patients with external digestive tract fistulas — an evaluation of our experience // Ann of Gastroenterology. 2005. <...> Kabanov1, I. A. Soloviev1, D. M. Yakovleva2, K. V. Sementsov1, A. V. Kradenov2 EXPERIENCE OF USING OF OCTREOTIDE-DEPOT IN PREVENTION OF THE DEVELOPMENT AND TREATMENT OF EXTERNAL PANCREATIC FISTULAS OF DIFFERENT GENESIS 1 Kirov Military Medical Academy, Saint-Petersburg; 2 Djanelidze Research Institute of Emergency Medicine, Saint-Petersburg In the period from 2011 till 2012 the Otcreotide-depot was used by the authors in treatment of 34 patients. <...> The patients were divided into two groups: the first group — the prevention of development and the second group — the treatment of external pancreatic fistulas. <...> Ocreotide-depot was applied in 17 patient of the first group: as part of the complex therapy of severe pancreatitis in 4 patients and after pacreaticoduodenectomy in 13 patients. <...> Ocreotide-depot was used in 17 patients of the second group: 7 cases of patients after different types of pancreatic resections and after external drainage of pancreatic <...>